Experienced in Tetanus

Florence Ader

Lyon, FR 
Experienced in Tetanus
Lyon, FR 
OverviewLocationsClinical Research

Overview

Florence Ader practices in Lyon, France. Ms. Ader is rated as an Experienced expert by MediFind in the treatment of Tetanus. Her top areas of expertise are Legionnaire Disease, COVID-19, Severe Acute Respiratory Syndrome (SARS), Bone Marrow Transplant, and Synovectomy.

Her clinical research consists of co-authoring 175 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Tetanus.

Gender
Female

Locations

Lyon, 69004, France
Other Locations
Villeurbanne, France
Saint-etienne-de-valoux, France
St Antoine Hospital, AP HP
Paris, France
Bron, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') or or Authorisation for Early Access (AAP). A Prospective Cohort.
Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') or or Authorisation for Early Access (AAP). A Prospective Cohort.
Enrollment Status: Completed
Publish Date: May 28, 2025
Intervention Type: Other
Multicenter Retrospective Cohort Study of Invasive Fungal Filamentous Fungal Infections in Liver Transplant Patients
Multicenter Retrospective Cohort Study of Invasive Fungal Filamentous Fungal Infections in Liver Transplant Patients
Enrollment Status: Completed
Publish Date: September 19, 2024
Multi-centre, Adaptive, Randomized Trial of the Safety and Efficacy of Treatments of COVID-19 in Hospitalized Adults
Multi-centre, Adaptive, Randomized Trial of the Safety and Efficacy of Treatments of COVID-19 in Hospitalized Adults
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Other, Drug
Study Drugs: Remdesivir, Lopinavir, Ritonavir, Interferon Beta-1A, Hydroxychloroquine, AZD7442
Study Phase: Phase 3
Human Endogenous Retroviruses in Acute Myeloid Leukemia: Expression and Immune Impact
Human Endogenous Retroviruses in Acute Myeloid Leukemia: Expression and Immune Impact
Enrollment Status: Withdrawn
Publish Date: August 22, 2022
Intervention Type: Other
View 3 Less Clinical Trials

175 Total Publications

Clinical research in rapid sequence during a pandemic: Lessons learned and the way forward.
Clinical research in rapid sequence during a pandemic: Lessons learned and the way forward.
Journal: Infectious diseases now
Published: May 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Ader's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 42 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile